These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21492978)

  • 1. Social isolation, C-reactive protein, and coronary heart disease mortality among community-dwelling adults.
    Heffner KL; Waring ME; Roberts MB; Eaton CB; Gramling R
    Soc Sci Med; 2011 May; 72(9):1482-8. PubMed ID: 21492978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.
    Folsom AR; Aleksic N; Catellier D; Juneja HS; Wu KK
    Am Heart J; 2002 Aug; 144(2):233-8. PubMed ID: 12177639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
    Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
    J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies.
    Pai JK; Mukamal KJ; Rexrode KM; Rimm EB
    PLoS One; 2008 Jan; 3(1):e1395. PubMed ID: 18167554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined effect of blood pressure and C-reactive protein with the risk of mortality from coronary heart and cardiovascular diseases.
    Kurl S; Jae SY; Voutilainen A; Laukkanen JA
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2051-2057. PubMed ID: 34090772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in southeastern New England.
    Eaton CB; Gramling R; Parker DR; Roberts MB; Lu B; Ridker PM
    Atherosclerosis; 2008 Sep; 200(1):221-7. PubMed ID: 18261732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep duration, C-reactive protein and risk of incident coronary heart disease--results from the Framingham Offspring Study.
    Liu J; Yuen J; Kang S
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):600-5. PubMed ID: 24548663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study.
    Soinio M; Marniemi J; Laakso M; Lehto S; Rönnemaa T
    Diabetes Care; 2006 Feb; 29(2):329-33. PubMed ID: 16443882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
    Yeboah J; McClelland RL; Polonsky TS; Burke GL; Sibley CT; O'Leary D; Carr JJ; Goff DC; Greenland P; Herrington DM
    JAMA; 2012 Aug; 308(8):788-95. PubMed ID: 22910756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of social integration to inflammatory marker concentrations in men and women 70 to 79 years.
    Loucks EB; Berkman LF; Gruenewald TL; Seeman TE
    Am J Cardiol; 2006 Apr; 97(7):1010-6. PubMed ID: 16563907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting under the skin: Social isolation and biological markers in the National Health and Aging Trends Study.
    Cudjoe TKM; Selvakumar S; Chung SE; Latkin CA; Roth DL; Thorpe RJ; Boyd CM
    J Am Geriatr Soc; 2022 Feb; 70(2):408-414. PubMed ID: 34698366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein and coronary heart disease in western Turkey.
    Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
    Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social isolation in childhood and adult inflammation: evidence from the National Child Development Study.
    Lacey RE; Kumari M; Bartley M
    Psychoneuroendocrinology; 2014 Dec; 50():85-94. PubMed ID: 25197797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.
    Kuller LH; Grandits G; Cohen JD; Neaton JD; Prineas R;
    Atherosclerosis; 2007 Nov; 195(1):122-8. PubMed ID: 17011566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants.
    Clarke R; Shipley M; Armitage J; Collins R; Harris W
    Br J Nutr; 2009 Jul; 102(2):279-84. PubMed ID: 19105853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.